Arrhythmias
Choice of anti-arrhythmic agent depends on the type of arrhythmia - see BNF and NICE guidance. These would mainly be initiated in secondary care.
Drug safety Update
March 2022: Amiodarone (Cordarone X): reminder of risks of treatment and need for patient monitoring and supervision
October 2011: Dronedarone (Multaq▼): cardiovascular, hepatic and pulmonary adverse events – new restrictions and monitoring requirements
NICE Guidance (also see drug-specific links below)
NG196: Atrial fibrillation: diagnosis & management, April 2021 (updated June 2021)
Local Guidance
Drug level monitoring of digoxin is recommended because it has a narrow therapeutic index and therefore should be used with caution in the elderly and in renal impairment. Therapeutic concentrations of digoxin are quoted as 0.8 - 2.2 micrograms/L, but results should be interpreted alongside clinical findings and serum potassium levels. Measurement of digoxin levels should be taken at least 6 hours post dose. See local Therapeutic Drug Monitoring Guidance.
Patients are at an increased risk of digoxin toxicity if hypokalaemia occurs.
Administration route: when changing from tablets to elixir, ONE 62.5micrograms tablet is approximately equivalent to 50micrograms(1mL) elixir.
Amiodarone requires careful monitoring. See BNF for cautions, side effects, interactions and monitoring.
Dronedarone is a derivative of amiodarone. It must be used second line to other anti-arrhythmic agents including amiodarone. See BNF for cautions, side effects, interactions and monitoring. There is a shared care guideline for prescribing.
***Note: Beta-adrenoceptor blockers atenolol and bisoprolol, Calcium Channel Blockers Diltiazem and Verapamil are also used for arrhythmias. ***
Pack | Price |
---|---|
28 tablet | £2.65 |
500 tablet |
Pack | Price |
---|---|
28 tablet | £2.53 |
500 tablet |
Pack | Price |
---|---|
28 tablet | £2.41 |
500 tablet |
Pack | Price |
---|---|
60 ml | £6.95 |
Pack | Price |
---|---|
5 ampoule | £3.30 |
Treatment of ventricular or prophylaxis of supraventricular arrhythmias
Pack | Price |
---|---|
28 tablet | £0.89 |
56 tablet | |
100 tablet |
Pack | Price |
---|---|
28 tablet | £1.35 |
30 tablet | |
56 tablet | |
100 tablet |
Supraventricular and ventricular arrhythmias
Pack | Price |
---|---|
28 tablet | £2.16 |
Pack | Price |
---|---|
28 tablet | £1.78 |
30 tablet | |
60 tablet |
Pack | Price |
---|---|
5 ampoule | £7.75 |
Supraventricular and ventricular arrhythmias
Pack | Price |
---|---|
40 capsule | |
84 capsule | £14.14 |
90 capsule | |
120 capsule |
Pack | Price |
---|---|
84 capsule |
Pack | Price |
---|---|
40 tablet | |
56 tablet | |
60 tablet | £32.08 |
Consultant cardiologist initiation only, shared care guidelines available.
Pack | Price |
---|---|
20 tablet | £23.37 |
60 tablet |
Supraventricular and ventricular arrhythmias
Pack | Price |
---|---|
60 tablet | £2.19 |
Pack | Price |
---|---|
60 tablet | £3.32 |
100 tablet |
Pack | Price |
---|---|
5 ampoule |
First choice in paroxysmal supraventricular tachycardia
Pack | Price |
---|---|
6 vial | £6.45 |
Pack | Price |
---|---|
6 vial | £16.05 |
Ventricular arrhythmias
Pack | Price |
---|---|
10 ampoule |
Pack | Price |
---|---|
1 pre-filled disposable injection |
Pack | Price |
---|---|
1 bag | |
15 bag |
Pack | Price |
---|---|
1 bag | |
15 bag |
Used for provocation testing in the diagnosis of Brugada syndrome
Pack | Price |
---|---|
5 ampoule |